To further substantiate the specific enrichment of F13A1‐ and CD1C‐expressing myeloid subsets in multiple primary tumours compared to normal tissues and single‐primary tumours, we firstly performed differential gene expression analysis between myeloid cells from each lesion and its corresponding adjacent non‐tumour tissue in each MPLC patient. This evidence concerns the gene CD1C and neoplasm.